Cargando…

A novel reverse transduction adenoviral array for the functional analysis of shRNA libraries

BACKGROUND: The identification of novel drug targets by assessing gene functions is most conveniently achieved by high-throughput loss-of-function RNA interference screening. There is a growing need to employ primary cells in such screenings, since they reflect the physiological situation more close...

Descripción completa

Detalles Bibliográficos
Autores principales: Oehmig, Angelika, Klotzbücher, Andrea, Thomas, Maria, Weise, Frank, Hagner, Ursula, Brundiers, Ralf, Waldherr, Dirk, Lingnau, Andreas, Knappik, Achim, Kubbutat, Michael HG, Joos, Thomas O, Volkmer, Hansjürgen
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2559852/
https://www.ncbi.nlm.nih.gov/pubmed/18816379
http://dx.doi.org/10.1186/1471-2164-9-441
_version_ 1782159680551780352
author Oehmig, Angelika
Klotzbücher, Andrea
Thomas, Maria
Weise, Frank
Hagner, Ursula
Brundiers, Ralf
Waldherr, Dirk
Lingnau, Andreas
Knappik, Achim
Kubbutat, Michael HG
Joos, Thomas O
Volkmer, Hansjürgen
author_facet Oehmig, Angelika
Klotzbücher, Andrea
Thomas, Maria
Weise, Frank
Hagner, Ursula
Brundiers, Ralf
Waldherr, Dirk
Lingnau, Andreas
Knappik, Achim
Kubbutat, Michael HG
Joos, Thomas O
Volkmer, Hansjürgen
author_sort Oehmig, Angelika
collection PubMed
description BACKGROUND: The identification of novel drug targets by assessing gene functions is most conveniently achieved by high-throughput loss-of-function RNA interference screening. There is a growing need to employ primary cells in such screenings, since they reflect the physiological situation more closely than transformed cell lines do. Highly miniaturized and parallelized approaches as exemplified by reverse transfection or transduction arrays meet these requirements, hence we verified the applicability of an adenoviral microarray for the elucidation of gene functions in primary cells. RESULTS: Here, we present microarrays of infectious adenoviruses encoding short hairpin RNA (shRNA) as a new tool for gene function analysis. As an example to demonstrate its application, we chose shRNAs directed against seven selected human protein kinases, and we have performed quantitative analysis of phenotypical responses in primary human umbilical vein cells (HUVEC). These microarrays enabled us to infect the target cells in a parallelized and miniaturized procedure without significant cross-contamination: Viruses were reversibly immobilized in spots in such a way that the seeded cells were confined to the area of the viral spots, thus simplifying the subsequent addressing of genetically modified cells for analysis. Computer-assisted image analysis of fluorescence images was applied to analyze the cellular response after shRNA expression. Both the expression level of knock-down target proteins as well as the functional output as measured by caspase 3 activity and DNA fractionation (TUNEL) were quantified. CONCLUSION: We have developed an adenoviral microarray technique suitable for miniaturized and parallelized analysis of gene function. The practicability of this technique was demonstrated by the analysis of several kinases involved in the activation of programmed cell death, both in tumor cells and in primary cells.
format Text
id pubmed-2559852
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-25598522008-10-03 A novel reverse transduction adenoviral array for the functional analysis of shRNA libraries Oehmig, Angelika Klotzbücher, Andrea Thomas, Maria Weise, Frank Hagner, Ursula Brundiers, Ralf Waldherr, Dirk Lingnau, Andreas Knappik, Achim Kubbutat, Michael HG Joos, Thomas O Volkmer, Hansjürgen BMC Genomics Methodology Article BACKGROUND: The identification of novel drug targets by assessing gene functions is most conveniently achieved by high-throughput loss-of-function RNA interference screening. There is a growing need to employ primary cells in such screenings, since they reflect the physiological situation more closely than transformed cell lines do. Highly miniaturized and parallelized approaches as exemplified by reverse transfection or transduction arrays meet these requirements, hence we verified the applicability of an adenoviral microarray for the elucidation of gene functions in primary cells. RESULTS: Here, we present microarrays of infectious adenoviruses encoding short hairpin RNA (shRNA) as a new tool for gene function analysis. As an example to demonstrate its application, we chose shRNAs directed against seven selected human protein kinases, and we have performed quantitative analysis of phenotypical responses in primary human umbilical vein cells (HUVEC). These microarrays enabled us to infect the target cells in a parallelized and miniaturized procedure without significant cross-contamination: Viruses were reversibly immobilized in spots in such a way that the seeded cells were confined to the area of the viral spots, thus simplifying the subsequent addressing of genetically modified cells for analysis. Computer-assisted image analysis of fluorescence images was applied to analyze the cellular response after shRNA expression. Both the expression level of knock-down target proteins as well as the functional output as measured by caspase 3 activity and DNA fractionation (TUNEL) were quantified. CONCLUSION: We have developed an adenoviral microarray technique suitable for miniaturized and parallelized analysis of gene function. The practicability of this technique was demonstrated by the analysis of several kinases involved in the activation of programmed cell death, both in tumor cells and in primary cells. BioMed Central 2008-09-24 /pmc/articles/PMC2559852/ /pubmed/18816379 http://dx.doi.org/10.1186/1471-2164-9-441 Text en Copyright © 2008 Oehmig et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology Article
Oehmig, Angelika
Klotzbücher, Andrea
Thomas, Maria
Weise, Frank
Hagner, Ursula
Brundiers, Ralf
Waldherr, Dirk
Lingnau, Andreas
Knappik, Achim
Kubbutat, Michael HG
Joos, Thomas O
Volkmer, Hansjürgen
A novel reverse transduction adenoviral array for the functional analysis of shRNA libraries
title A novel reverse transduction adenoviral array for the functional analysis of shRNA libraries
title_full A novel reverse transduction adenoviral array for the functional analysis of shRNA libraries
title_fullStr A novel reverse transduction adenoviral array for the functional analysis of shRNA libraries
title_full_unstemmed A novel reverse transduction adenoviral array for the functional analysis of shRNA libraries
title_short A novel reverse transduction adenoviral array for the functional analysis of shRNA libraries
title_sort novel reverse transduction adenoviral array for the functional analysis of shrna libraries
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2559852/
https://www.ncbi.nlm.nih.gov/pubmed/18816379
http://dx.doi.org/10.1186/1471-2164-9-441
work_keys_str_mv AT oehmigangelika anovelreversetransductionadenoviralarrayforthefunctionalanalysisofshrnalibraries
AT klotzbucherandrea anovelreversetransductionadenoviralarrayforthefunctionalanalysisofshrnalibraries
AT thomasmaria anovelreversetransductionadenoviralarrayforthefunctionalanalysisofshrnalibraries
AT weisefrank anovelreversetransductionadenoviralarrayforthefunctionalanalysisofshrnalibraries
AT hagnerursula anovelreversetransductionadenoviralarrayforthefunctionalanalysisofshrnalibraries
AT brundiersralf anovelreversetransductionadenoviralarrayforthefunctionalanalysisofshrnalibraries
AT waldherrdirk anovelreversetransductionadenoviralarrayforthefunctionalanalysisofshrnalibraries
AT lingnauandreas anovelreversetransductionadenoviralarrayforthefunctionalanalysisofshrnalibraries
AT knappikachim anovelreversetransductionadenoviralarrayforthefunctionalanalysisofshrnalibraries
AT kubbutatmichaelhg anovelreversetransductionadenoviralarrayforthefunctionalanalysisofshrnalibraries
AT joosthomaso anovelreversetransductionadenoviralarrayforthefunctionalanalysisofshrnalibraries
AT volkmerhansjurgen anovelreversetransductionadenoviralarrayforthefunctionalanalysisofshrnalibraries
AT oehmigangelika novelreversetransductionadenoviralarrayforthefunctionalanalysisofshrnalibraries
AT klotzbucherandrea novelreversetransductionadenoviralarrayforthefunctionalanalysisofshrnalibraries
AT thomasmaria novelreversetransductionadenoviralarrayforthefunctionalanalysisofshrnalibraries
AT weisefrank novelreversetransductionadenoviralarrayforthefunctionalanalysisofshrnalibraries
AT hagnerursula novelreversetransductionadenoviralarrayforthefunctionalanalysisofshrnalibraries
AT brundiersralf novelreversetransductionadenoviralarrayforthefunctionalanalysisofshrnalibraries
AT waldherrdirk novelreversetransductionadenoviralarrayforthefunctionalanalysisofshrnalibraries
AT lingnauandreas novelreversetransductionadenoviralarrayforthefunctionalanalysisofshrnalibraries
AT knappikachim novelreversetransductionadenoviralarrayforthefunctionalanalysisofshrnalibraries
AT kubbutatmichaelhg novelreversetransductionadenoviralarrayforthefunctionalanalysisofshrnalibraries
AT joosthomaso novelreversetransductionadenoviralarrayforthefunctionalanalysisofshrnalibraries
AT volkmerhansjurgen novelreversetransductionadenoviralarrayforthefunctionalanalysisofshrnalibraries